Penn State Hershey Medical Center home Penn State Hershey Medical Center home Penn State Hershey: Patient Care home Penn State Hershey: Education home Penn State Hershey: Research home Penn State Hershey: Community home
Penn State Hershey Health Information Library
  Library Home
  Find A Physician
  Find A Practice
  Request An Appointment
  Search Clinical Studies
  Classes and Support Groups
  Ask A Health Librarian
  Subscribe to eNewsletters


Penn State Hershey Health Information Centers
  Bone and Joint
  Cancer
  Children
  Heart
  Men
  Neurology
  Pregnancy
  Seniors
  Women

        Follow Us

New Device Cleared for Gastrointestinal Bleeding

MONDAY, May 7, 2018 (HealthDay News) -- The U.S. Food and Drug Administration has approved the new Hemospray device to help control bleeding of the gastrointestinal tract.

Bleeding in the stomach, intestines, colon or rectum may be caused by factors such as ulcers, malformed blood vessels, diverticulosis, cancer or inflammatory bowel disease, the FDA explained in a news release Monday.

The new device "provides an additional, non-surgical option for treating upper and lower GI bleeding in certain patients, and may help reduce the risk of death from a GI bleed for many patients," said Dr. Binita Ashar, director of the FDA's division of surgical devices.

Hemospray is an aerosol spray comprised of a blend of minerals, which is applied during an endoscopic procedure. In clinical studies of 228 people with upper or lower GI bleeding, 95 percent of cases had bleeding stopped within five minutes of the therapy's application, the agency said.

Re-bleeding, usually within 72 hours, was reported in about 20 percent of cases. And bowel perforation was observed in about 1 percent of patients, the FDA said.

People who have either an existing gastrointestinal fistula or who are at high risk of bowel perforation should avoid the therapy, the agency warned.

The device is produced by Wilson-Cook Medical Inc. of Winston-Salem, NC.

More information

Visit the FDA to learn more.



-- Scott Roberts

Copyright © 2018 HealthDay. All rights reserved.